C

ChemoCentryx

109 employees

ChemoCentryx is a biopharmaceutical company that develops medications for inflammatory and autoimmune diseases and cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
ANCA-associated vasculitis
AURORA
Chemokine
Complement Receptor
Drug Discovery
C3 Glomerulopathy
inflammatory disorders
Medical Device
Biopharmaceutical
autoimmune diseases
Diabetic Nephropathy
orphan and rare diseases
Health Care
Inflammatory Bowel Disease (IBD)
Chemoattractant System
LUMINA
immuno-oncology
Hidradenitis Suppurativa
Pancreatic Cancer
Chronic Kidney Disease
Avacopan
TAVNEOS
oral therapeutics
Small Molecule Therapeutics
ADVOCATE
Rheumatoid Arthritis (RA)

Date founded

1997

FAQ